http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007005940-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_825e045cf72d7f1c2e2adfc6b1d530ae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ebb6a553affdc364c91cffe3baf12564
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05fa61aac70de13289dd6d392ba7e897
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1733fe4c594eccc7c76ec01b284751fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e65f3aefa7c3daf9d68605be5a19b24c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-498
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
filingDate 2006-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2bd9802df6706361b4d1bf29e1e709d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f2fa4ee0a9f81d8d425e0b1dae66295
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f56660580fa8790aea51716dd2aa2c37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2923cd5d043647a24c75582042f87d2
publicationDate 2007-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2007005940-A3
titleOfInvention Combinations of eszopiclone and didesmethylsibutramine, and methods of treatment of menopause and mood, anxiety, and cognitive disorders
abstract One aspect of the present invention relates to pharmaceutical compositions containing two or more active agents that when taken together can be used to treat, e.g., menopause, mood disorders, anxiety disorders, or cognitive disorders. The first component of the pharmaceutical composition is a sedative eszopiclone. The second component of the pharmaceutical composition is didesmethylsibutramine or (S)-didesmethylsibutramine. The present invention also relates to a method of treating menopause, perimenopause, mood disorders, anxiety disorders, and cognitive disorders.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8329950-B2
priorityDate 2005-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4806570-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5786357-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID969472
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226415931

Total number of triples: 27.